Inhibition of Tumor Lymphangiogenesis is an Important Part that EGFR-TKIs Play in the Treatment of NSCLC

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been widely used to treat non-small cell lung cancer (NSCLC) because they inhibit tumour growth and metastasis. However, the underlying mechanisms are not fully understood. Here, we investigate whether anti-lymphangiogene...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yan, Yang, Xinying, Liu, Hongchun, Cai, Minghui, Shentu, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930403/
https://www.ncbi.nlm.nih.gov/pubmed/31892990
http://dx.doi.org/10.7150/jca.35448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930403/
https://www.ncbi.nlm.nih.gov/pubmed/31892990
http://dx.doi.org/10.7150/jca.35448

Ejemplares similares